M Bayes, X Rabasseda, JR Prous - Methods and findings in …, 2006 - journals.prous.com Contributing Editors: P. Cole, C. Orellana, JA Vallès, RM a . Antonijoan, KP Mohana Priya,
M. Priya, V. Renuga, R. Sree Lekha, B. Priya, A. Tomillero, G. Krithiga and E. Banu Rekha. Cited by 148 - Related articles - All 9 versions
MC Riddle - Endocrinology and metabolism clinics of North America, 2005 - Elsevier We have long known, but now understand more fully that type 2 diabetes is common,
complex, and as treated presently, leads to severe medical consequences. In type 1
diabetes, hyperglycemia is the leading cause of harm. In type 2 diabetes, despite a well- ... Cited by 68 - Related articles - All 3 versions
CJ Bailey - Diabetes Obesity and Metabolism, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 50 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org SM Strowig, ML Avilés-Santa, P Raskin - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—HbA 1c levels decreased in both groups during dual therapy and improved further
during triple therapy (INS + MET 7.0 ± 0.8, INS + TGZ 6.2 ± 0.8, P < 0.0001; INS + MET, add TGZ
6.1 ± 0.4%, P < 0.001; INS + TGZ, add MET 5.8 ± 0.6%, P < 0.05; and INS + TGZ vs. INS + ... Cited by 49 - Related articles - BL Direct - All 5 versions
PS Jellinger, JA Davidson, L Blonde, D Einhorn, G … - Endocrine Practice, 2007 - AACE The accompanying Diabetes Road Maps were created to provide direction for clinicians in achieving
the hemo- globin A1c (A1C) glycemic goals established by the American College of Endocrinology
(ACE) and the American Association of Clinical Endocrinologists (AACE). The three Road ... Cited by 30 - Related articles - All 6 versions
L Monnier, C Colette - Diabetes and Metabolism, 2006 - Elsevier There are many reasons to believe that in the near future, the treatment of patients with Type
2 diabetes will be characterised by an increased use of insulin therapy. To ensure that insulin
regimens are acceptable to patients, and implemented by physicians, they should be as ... Cited by 27 - Related articles - BL Direct - All 4 versions
RM Bergenstal, JR Gavin - The American journal of medicine, 2005 - Elsevier Self-monitoring of blood glucose (SMBG) is an underutilized but integral part of disease management
for patients with both type 1 and type 2 diabetes. Guidelines on the recommended frequency
and timing of SMBG vary among international diabetes associations, and patients are ... Cited by 26 - Related articles - All 4 versions
- ►ascensia.ch [PDF] E Renard - The American journal of medicine, 2005 - Elsevier Several methods, each with differing utility and limitations, exist for monitoring glycemic
control. Hemoglobin A 1c (HbA 1c ) is considered the standard measure of long-term glycemic
control, and HbA 1c levels are strongly associated with complications of diabetes. ... Cited by 25 - Related articles - All 10 versions
SM Strowig, P Raskin - Diabetes Obesity and Metabolism, 2005 - interscience.wiley.com The biguanide, metformin, sensitizes the liver to the effect of insulin, suppressing hepatic glucose
output. Thiazolidinediones such as rosiglitazone and pioglitazone enhance insulin-mediated
glucose disposal, leading to reduced plasma insulin concentrations. These classes of ... Cited by 20 - Related articles - BL Direct - All 5 versions
DS Bell, F Ovalle - Diabetes Obesity and Metabolism, 2006 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 17 - Related articles - BL Direct - All 4 versions
